Grupo Fleury
Luiz Carlos Trabuco Cappi, nominated for reelection as an effective member of the Board of Directors, is an external member graduated in Philosophy with a postgraduate degree in Socio-Psychology from the São Paulo School of Sociology and Politics. He started his career 48 years ago, dedicating his entire professional life to the Bradesco Organization. He was Officer of Investor Relations and, as Vice Chief Executive Officer of Banco Bradesco, from 1999 to 2009, he accumulated, for 6 (six) years, the Chaimanship of the Grupo Bradesco Seguros. He chaired the Executive Board of Banco Bradesco from March 2009 to March 2018, accumulating the position of Vice-Chairman of the Board of Directors until October 2017, when he was appointed Chairman of the Board of Directors. He was Chairman of the Board of Directors of Odontoprev SA, Member of the Board of Directors of ArcelorMittal Brasil, Member of the Strategic Committee of Vale SA, President of the Marketing and Funding Committee of the Brazilian Association of Real Estate Loans and Savings Companies – ABECIP, President of the Associação Nacional da Previdência Privada (National Association of Pension Fund) – ANAPP, President of the National Supplementary Health Federation – FENASAÚDE, President of the Council of Representatives and of the Executive Board of the National Confederation of Financial Institutions – CNF, Member of the Superior Council and Vice-President of the National Confederation of General Insurance, Private Pension and Life, Supplementary Health and Capitalization Companies, Member of the Board of Directors and Advisory Board of FEBRABAN – Brazilian Federation of Banks and Member of the Association Internationale pour I‘Etude de I‘Economie de I‘Assurance – Association of Genève , Geneva, Switzerland.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Grupo Fleury
1 followers
With almost 100 years, Grupo Fleury is one of the most respected medical and health organizations in Brazil, recognized by the community and public opinion for its technical, medical, service and management excellence. In recent years, it has accelerated its growth towards being an integrated, preventive and hybrid health ecosystem, combining physical and digital offers. With this integrated system, it has increasingly been able to support the physician's clinical conduct in the search for solutions that meet the needs of each patient, while contributing to the sustainability of the system. In addition to diagnostic medicine, it has expanded its activities to the stages of prevention, primary, secondary and tertiary care. With more than 13 thousand employees and 3 thousand doctors, the company is present in the markets of São Paulo, Rio de Janeiro, Rio Grande do Sul, Paraná, Bahia, Pernambuco, Rio Grande do Norte, Maranhão, Espírito Santo and Distrito Federal. The company has established itself as one of the biggest references in best social, economic and environmental practices (Environmental, Social and Governance - ESG). Recently, it was recognized and was included for the second time in the 'Dow Jones Sustainability Index (DJSI)', of the New York Stock Exchange, in the DJSI Emerging Markets portfolio, being the only company in the Health sector in the Americas to be part of of the index.